International Equities Outperform: Analyzing SPDW's Value and Diversification

Morgan Housel

Award-winning financial writer and partner at The Collaborative Fund, exploring the psychology of money.

In recent years, global equity markets have presented compelling opportunities beyond the United States. The State Street SPDR Portfolio Developed World ex-US ETF (SPDW) stands out, having consistently outperformed the S&P 500 in both 2025 and 2026, building on impressive earlier gains. This strong showing reflects a shift in market dynamics, where international stocks are gaining traction. A primary driver behind this resurgence is the appealing valuations found in developed international markets, particularly as the appreciation of the U.S. dollar has stabilized against other major currencies.

SPDW's portfolio boasts significantly lower price-to-earnings ratios compared to the S&P 500, whether considering current or projected earnings. This valuation gap suggests that international equities offer more growth potential for every dollar invested. Furthermore, the ETF provides extensive diversification by investing in approximately 2,452 individual companies across numerous national economies. This broad exposure helps mitigate specific company or country-level risks, offering investors a more stable and varied investment landscape.

However, like any investment, SPDW carries its own set of considerations. A significant allocation to cyclical sectors and an inherent short exposure to the U.S. dollar introduce potential vulnerabilities. These factors could amplify losses during economic downturns or periods of heightened market volatility. Investors should therefore weigh these risks against the attractive valuations and diversification benefits when considering SPDW as part of their investment strategy.

Investing in international markets through funds like SPDW can offer a pathway to participate in global economic growth and benefit from diverse valuation opportunities. By carefully assessing both the potential rewards and inherent risks, investors can make informed decisions that align with their long-term financial objectives and contribute to a well-rounded portfolio.

you may like

youmaylikeicon
Taseko Mines: Florence Project Transforms Production Landscape

Taseko Mines: Florence Project Transforms Production Landscape

By Michele Ferrero
Federal Reserve's Preferred Inflation Gauge Hits 3.3% in April, Highest Since 2023

Federal Reserve's Preferred Inflation Gauge Hits 3.3% in April, Highest Since 2023

By Suze Orman
Investor Sentiment on Stock Market: Optimism Rises, Neutrality and Pessimism Decline

Investor Sentiment on Stock Market: Optimism Rises, Neutrality and Pessimism Decline

By Suze Orman
Mastercard: A Resilient Investment Opportunity Amidst Market Fluctuations

Mastercard: A Resilient Investment Opportunity Amidst Market Fluctuations

By Nouriel Roubini
F&G Annuities & Life: Overcoming Undervaluation and Market Concerns

F&G Annuities & Life: Overcoming Undervaluation and Market Concerns

By David Rubenstein
RUI Holdings IPO: A Deep Dive into Its Overvalued Logistics Business

RUI Holdings IPO: A Deep Dive into Its Overvalued Logistics Business

By Robert Kiyosaki
Zscaler Stock Plummets Amidst Disappointing Revenue Outlook

Zscaler Stock Plummets Amidst Disappointing Revenue Outlook

By Nouriel Roubini
Personalis: A Deep Dive into its Cancer Testing Biotech and Market Potential

Personalis: A Deep Dive into its Cancer Testing Biotech and Market Potential

By Suze Orman
Eversource Energy: Navigating Regulatory Challenges for Long-Term Growth

Eversource Energy: Navigating Regulatory Challenges for Long-Term Growth

By Morgan Housel
Top Real Estate Apps for Property Search and Investment

Top Real Estate Apps for Property Search and Investment

By Lisa Jing
Semiconductor Stocks Outpace Analyst Expectations

Semiconductor Stocks Outpace Analyst Expectations

By Michele Ferrero
Understanding Chase Bank CD Rates: Key Features, Pros, Cons, and Alternatives

Understanding Chase Bank CD Rates: Key Features, Pros, Cons, and Alternatives

By Suze Orman
Apogee Therapeutics: Advancing Eczema Treatment with Innovative Dosing and Strategic Funding

Apogee Therapeutics: Advancing Eczema Treatment with Innovative Dosing and Strategic Funding

By Fareed Zakaria
Micron: The Market's Misjudgment of Memory Cyclicality

Micron: The Market's Misjudgment of Memory Cyclicality

By Robert Kiyosaki
A Comprehensive Look at Chase Savings Accounts and Alternatives

A Comprehensive Look at Chase Savings Accounts and Alternatives

By Lisa Jing